PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • CT contrast injectors • MRI contrast injectors • Angiography contrast injectors • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increase in use of syringeless contrast media injectors • Growing demand for automated contrast injectors • Emergence of triple head contrast media injectors PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bayer • Bracco • Guerbet • Medtron • Nemoto Kyorindo • ulrich medical PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global medical devices market Exhibit 03: Market characteristics Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Contrast injectors – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global contrast injectors market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: CT contrast injectors – Market size and forecast 2017-2022 ($ mn) Exhibit 21: CT contrast injectors – Year-over-year growth 2018-2022 (%) Exhibit 22: MRI contrast injectors – Market size and forecast 2017-2022 ($ mn) Exhibit 23: MRI contrast injectors – Year-over-year growth 2018-2022 (%) Exhibit 24: Angiography contrast injectors – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Angiography contrast injectors – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Contrast injectors – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Bayer overview Exhibit 46: Bayer – Business segments Exhibit 47: Bayer – Organizational developments Exhibit 48: Bayer – Geographic focus Exhibit 49: Bayer – Segment focus Exhibit 50: Bayer – Key offerings Exhibit 51: Bracco overview Exhibit 52: Bracco – Business segments Exhibit 53: Bracco – Organizational developments Exhibit 54: Bracco – Geographic focus Exhibit 55: Bracco – Segment focus Exhibit 56: Bracco – Key offerings Exhibit 57: Guerbet overview Exhibit 58: Guerbet – Business segments Exhibit 59: Guerbet – Organizational developments Exhibit 60: Guerbet – Geographic focus Exhibit 61: Guerbet – Segment focus Exhibit 62: Guerbet – Key offerings Exhibit 63: Medtron overview Exhibit 64: Medtron – Business segments Exhibit 65: Medtron – Organizational developments Exhibit 66: Medtron – Geographic focus Exhibit 67: Medtron – Segment focus Exhibit 68: Medtron – Key offerings Exhibit 69: Nemoto Kyorindo overview Exhibit 70: Nemoto Kyorindo – Business segments Exhibit 71: Nemoto Kyorindo – Organizational developments Exhibit 72: Nemoto Kyorindo – Geographic focus Exhibit 73: Nemoto Kyorindo – Segment focus Exhibit 74: Nemoto Kyorindo – Key offerings Exhibit 75: ulrich medical overview Exhibit 76: ulrich medical – Business segments Exhibit 77: ulrich medical – Organizational developments Exhibit 78: ulrich medical – Geographic focus Exhibit 79: ulrich medical – Segment focus Exhibit 80: ulrich medical – Key offerings

Bayer Bracco Guerbet Medtron Nemoto Kyorindo ulrich medical